<DOC>
	<DOCNO>NCT00963040</DOCNO>
	<brief_summary>The objective prospective , randomize , double-blind , parallel-group , placebo-controlled study determine effectiveness intranasal oxytocin subject suffer chronic daily headache . The primary outcome measure reduction headache intensity drug administration ; secondary outcome measure headache symptom , nausea , vomit , photophobia , phonophobia . Additional secondary outcome measure intake rescue medication patient satisfaction period 24 hour .</brief_summary>
	<brief_title>Effect Intranasal Oxytocin Headache Chronic Daily Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Headache Disorders</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>1 . Headache equal 15 day per month least 6 month ; headache migraine tension . 2 . More half monthly headache moderate severe intensity 4point categorical pain rating scale assess 6 high 11point numerical pain rating scale . 3 . Headaches typically last least 4 hour . 4 . Subjects stable headache treatment , , least 2 month . 1 . Headache symptom assess predominately occipital . 2 . Allergy oxytocin . 3 . History addictive behavior ( e.g . alcoholism , drug abuse ) . 4 . History significant psychiatric disorder . 5 . History clinicallysignificant , functionallyimpairing cardiovascular pulmonary disease . 6 . Upperrespiratory tract infection time randomization . 7 . Past current history condition may hinder study procedure confuse interpretation data . 8 . Nasal obstruction cause determine screen . 9 . Major surgery trauma within 4 week screen . 10 . Women pregnant evidence serum HCG , nursing , try conceive . 11 . Use intranasally administer medication , example , vasoconstrictor corticosteroid , within 2 week randomization . 12 . Use investigational medication device within 30 day randomization . 13 . Unable unwilling adhere studyspecific procedure restriction . 14 . Any condition opinion investigator would compromise safety subject quality data . 15 . Alanine aminotransaminase ( ALT ) aspartate aminotransaminase ( AST ) equal great 3 time upper limit normal ( ULN ) . 16 . Serum creatinine equal great 1.8 mg/dL . Resting , sit systolic blood pressure equal great 160 mmHg diastolic blood pressure equal great 100 mmHg screening . For patient previously diagnose hypertension , antihypertensive medication must stable least 30 day prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>intranasal oxytocin</keyword>
	<keyword>acute headache treatment</keyword>
	<keyword>chronic daily headache</keyword>
</DOC>